نتائج البحث 571-580 من 3474 لعملية البحث عن new arthritis treatments
Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma.
We aim to identify the reasons why certain therapies work and others don't and as result- develop new treatments for blood cancers. ... Therapy for the Treatment ...
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
The purpose of this study is to describe a new surgical technique for nipple reconstruction in female-to-male transgender chest wall reconstruction and ...
Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD. Accurate, MR based kidney volume measurements are the ...
To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...
Physiatrist; Palliative Care Specialist ... Cancer survivorship program, Palliative care, Hospice care ... Arthritis, Herniated disk, Neck pain, Cervical ...
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...
... Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer ... new tests to detect early cancer in the cohort of ... arthritis (RA), and anti- ...
... arthritis (RA), and anti-neutrophil cytoplasmic antibody (ANCA) associated ... Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.